Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
Latest Quarterly or Annual Filing
Latest Current Report
Latest Proxy Statement
View All SEC Filings
View and filter by group or type
View All Filings